A systems view of genetics in chronic kidney disease

Kidney International

Volumn 81, Issue 1, 2012, Pages 14-21

  Keller, Benjamin J ^a   Martini, Sebastian ^b   Sedor, John R ^c   Kretzler, Matthias ^b  

^a EASTERN MICHIGAN UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

diabetic nephropathy; gene expression; genetic renal disease; molecular genetics; transcription regulation

Indexed keywords

AMINO ACID SEQUENCE; CHRONIC KIDNEY DISEASE; DISEASE COURSE; DNA MODIFICATION; ENVIRONMENTAL FACTOR; EXPERIMENTAL MODEL; FRMD3 GENE; GENE; GENE CONTROL; GENE DELETION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE LOCUS; GENE MAPPING; GENE TARGETING; GENETIC ASSOCIATION; GENETIC PARAMETERS; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN GENETICS; KIDNEY FUNCTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; REVIEW;

EID: 83655167205     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2011.359     Document Type: Review

References (64)

1. Manolio TA, Collins FS, Cox NJ et al. Finding the missing heritability of complex diseases. Nature 2009; 461: 747-753.
2. Ferguson R, Grim CE, Opgenorth TJ. A familial risk of chronic renal failure among blacks on dialysis? J Clin Epidemiol 1988; 41: 1189-1196. (Pubitemid 19036521)
3. Gudbjartsson DF, Holm H, Indridason OS et al. Association of variants at UMOD with chronic kidney disease and kidney stones-role of age and comorbid diseases. PLoS Genet 2010; 6: e1001039.
4. Pezzolesi MG, Katavetin P, Kure M et al. Confirmation of genetic associations at ELMO1 in the GoKinD collection supports its role as a susceptibility gene in diabetic nephropathy. Diabetes 2009; 58: 2698-2702.
5. Ng DPK, Tai BC, Koh D et al. Angiotensin-I converting enzyme insertion/deletion polymorphism and its association with diabetic nephropathy: a meta-analysis of studies reported between 1994 and 2004 and comprising 14,727 subjects. Diabetologia 2005; 48: 1008-1016. (Pubitemid 40767996)
6. Kö ttgen A, Pattaro C, Bö ger CA et al. New loci associated with kidney function and chronic kidney disease. Nat Genet 2010; 42: 376-384.
7. Greene CN, Keong LM, Cordovado SK et al. Sequence variants in the PLEKHH2 region are associated with diabetic nephropathy in the GoKinD study population. Hum Genet 2008; 124: 255-262.
8. Tzur S, Rosset S, Shemer R et al. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene. Hum Genet 2010; 128: 345-350.
9. Freedman BI, Kopp JB, Langefeld CD et al. The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans. J Am Soc Nephrol 2010; 21: 1422-1426.
10. Maeda S, Kobayashi M-A, Araki S-I et al. A single nucleotide polymorphism within the acetyl-coenzyme A carboxylase beta gene is associated with proteinuria in patients with type 2 diabetes. PLoS Genet 2010; 6: e1000842.
11. Pezzolesi MG, Poznik GD, Mychaleckyj JC et al. Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes. Diabetes 2009; 58: 1403-1410.
12. Stanescu HC, Arcos-Burgos M, Medlar A et al. Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy. N Engl J Med 2011; 364: 616-626.
13. Gharavi AG, Kiryluk K, Choi M et al. Genome-wide association study identifies susceptibility loci for IgA nephropathy. Nat Genet 2011; 43: 321-327.
14. Jafari Y, Rahimi Z, Vaisi-Raygani A et al. Interaction of eNOS polymorphism with MTHFR variants increase the risk of diabetic nephropathy and its progression in type 2 diabetes mellitus patients. Mol Cell Biochem 2011; 353: 22-34.
15. Tien K-J, Tu S-T, Chou C-W et al. Apolipoprotein E polymorphism and the progression of diabetic nephropathy in type 2 diabetes. Am J Nephrol 2011; 33: 231-238.
16. Lee JS, Park H-K, Suh J-S et al. Toll-like receptor 1 gene polymorphisms in childhood IgA nephropathy: a case-control study in the Korean population. Int J Immunogenet 2011; 38: 133-138.
17. Qin L, Lv J, Zhou X et al. Association of IRF5 gene polymorphisms and lupus nephritis in a Chinese population. Nephrology (Carlton) 2010; 15: 710-713.
18. Chen S-Y, Chen C-H, Huang Y-C et al. Effect of IL-6 C-572G polymorphism on idiopathic membranous nephropathy risk in a Han Chinese population. Ren Fail 2010; 32: 1172-1176.
19. Kim S, Chin HJ, Na KY et al. Single nucleotide polymorphisms in the phospholipase A(2) receptor gene are associated with genetic susceptibility to idiopathic membranous nephropathy. Nephron Clin Pract 2011; 117: c253-c258.
20. Genovese G, Friedman DJ, Ross MD et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 2010; 329: 841-845.
21. Edenberg HJ, Liu Y. Laboratory methods for high-throughput genotyping. Cold Spring Harb Protoc 2009; 2009 pdb.top62.
22. He JC, Chuang PY, Ma'ayan A et al. Systems biology approach of kidney disease. Kidney Int; e-pub ahead of print 31 August 2011.
23. Dekker J. Gene regulation in the third dimension. Science 2008; 319: 1793-1794. (Pubitemid 351451557)
24. Cookson W, Liang L, Abecasis G et al. Mapping complex disease traits with global gene expression. Nat Rev Genet 2009; 10: 184-194.
25. Cheung VG, Spielman RS. Genetics of human gene expression: mapping DNA variants that influence gene expression. Nat Rev Genet 2009; 10: 595-604.
26. Wheeler HE, Metter EJ, Tanaka T et al. Sequential use of transcriptional profiling, expression quantitative trait mapping, and gene association implicates MMP20 in human kidney aging. PLoS Genet 2009; 5: e1000685.
27. Nica AC, Montgomery SB, Dimas AS et al. Candidate causal regulatory effects by integration of expression QTLs with complex trait genetic associations. PLoS Genet 2010; 6: e1000895.
28. Nicolae DL, Gamazon E, Zhang W et al. Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS. PLoS Genet 2010; 6: e1000888.
29. Babak T, Garrett-Engele P, Armour CD et al. Genetic validation of whole-transcriptome sequencing for mapping expression affected by cis-regulatory variation. BMC Genomics 2010; 11: 473.
30. Veyrieras J-B, Kudaravalli S, Kim SY et al. High-resolution mapping of expression-QTLs yields insight into human gene regulation. PLoS Genet 2008; 4: e1000214.
31. Breitling R, Li Y, Tesson BM et al. Genetical genomics: spotlight on QTL hotspots. PLoS Genet 2008; 4: e1000232.
32. Chen Y, Zhu J, Lum PY et al. Variations in DNA elucidate molecular networks that cause disease. Nature 2008; 452: 429-435. (Pubitemid 351450844)
33. Emilsson V, Thorleifsson G, Zhang B et al. Genetics of gene expression and its effect on disease. Nature 2008; 452: 423-428. (Pubitemid 351450845)
34. Schadt EE, Molony C, Chudin E et al. Mapping the genetic architecture of gene expression in human liver. PLoS Biol 2008; 6: e107.
35. Zhu J, Zhang B, Smith EN et al. Integrating large-scale functional genomic data to dissect the complexity of yeast regulatory networks. Nat Genet 2008; 40: 854-861. (Pubitemid 351913653)
36. Listgarten J, Kadie C, Schadt EE et al. Correction for hidden confounders in the genetic analysis of gene expression. Proc Natl Acad Sci USA 2010; 107: 16465-16470.
37. Zhong H, Beaulaurier J, Lum PY et al. Liver and adipose expression associated SNPs are enriched for association to type 2 diabetes. PLoS Genet 2010; 6: e1000932.
38. Kö ttgen A, Glazer NL, Dehghan A et al. Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet 2009; 41: 712-717.
39. Schmid H, Boucherot A, Yasuda Y et al. Modular activation of nuclear factor-B transcriptional programs in human diabetic nephropathy. Diabetes 2006; 55: 2993-3003. (Pubitemid 44923635)
40. Cohen CD, Frach K, Schlö ndorff D et al. Quantitative gene expression analysis in renal biopsies: a novel protocol for a high-throughput multicenter application. Kidney Int 2002; 61: 133-140. (Pubitemid 34075139)
41. Yasuda Y, Cohen CD, Henger A et al. Gene expression profiling analysis in nephrology: towards molecular definition of renal disease. Clin Exp Nephrol 2006; 10: 91-98. (Pubitemid 43961600)
42. Lindenmeyer MT, Eichinger F, Sen K et al. Systematic analysis of a novel human renal glomerulus-enriched gene expression dataset. PLoS ONE 2010; 5: e11545.
43. Lindenmeyer MT, Kretzler M, Boucherot A et al. Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy. J Am Soc Nephrol 2007; 18: 1765-1776. (Pubitemid 46870313)
44. Cohen CD, Klingenhoff A, Boucherot A et al. Comparative promoter analysis allows de novo identification of specialized cell junctionassociated proteins. Proc Natl Acad Sci USA 2006; 103: 5682-5687.
45. Maciel TT, Kempf H, Campos AH. Targeting bone morphogenetic protein signaling on renal and vascular diseases. Curr Opin Nephrol Hypertens 2010; 19: 26-31.
46. Rudnicki M, Perco P, Enrich J et al. Hypoxia response and VEGF-A expression in human proximal tubular epithelial cells in stable and progressive renal disease. Lab Invest 2009; 89: 337-346.
47. Si H, Banga RS, Kapitsinou P et al. Human and murine kidneys show gender-and species-specific gene expression differences in response to injury. PLoS ONE 2009; 4: e4802.
48. Perco P, Oberbauer R. Integrative analysis of-omics data and histologic scoring in renal disease and transplantation: renal histogenomics. Semin Nephrol 2010; 30: 520-530.
49. Terzic A, Perez-Terzic C. Channelopathies: decoding disease pathogenesis. Sci Transl Med 2010; 2: 42ps37.
50. Clark RH, McTaggart JS, Webster R et al. Muscle dysfunction caused by a KATP channel mutation in neonatal diabetes is neuronal in origin. Science 2010; 329: 458-461.
51. Musunuru K, Strong A, Frank-Kamenetsky M et al. From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus. Nature 2010; 466: 714-719.
52. Ragvin A, Moro E, Fredman D et al. Long-range gene regulation links genomic type 2 diabetes and obesity risk regions to HHEX, SOX4, and IRX3. Proc Natl Acad Sci USA 2010; 107: 775-780.
53. Alexander RP, Fang G, Rozowsky J et al. Annotating non-coding regions of the genome. Nat Rev Genet 2010; 11: 559-571.
54. Kikuta H, Laplante M, Navratilova P et al. Genomic regulatory blocks encompass multiple neighboring genes and maintain conserved synteny in vertebrates. Genome Res 2007; 17: 545-555. (Pubitemid 46715504)
55. Visel A, Zhu Y, May D et al. Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice. Nature 2010; 464: 409-412.
56. Sato Y, Wharram BL, Lee SK et al. Urine podocyte mRNAs mark progression of renal disease. J Am Soc Nephrol 2009; 20: 1041-1052.
57. Jansen RC, Tesson BM, Fu J et al. Defining gene and QTL networks. Curr Opin Plant Biol 2009; 12: 241-246.
58. Romanoski CE, Lee S, Kim MJ et al. Systems genetics analysis of gene-byenvironment interactions in human cells. Am J Hum Genet 2010; 86: 399-410.
59. Plaisier CL, Horvath S, Huertas-Vazquez A et al. A systems genetics approach implicates USF1, FADS3, and other causal candidate genes for familial combined hyperlipidemia. PLoS Genet 2009; 5: e1000642.
60. Wentzell AM, Rowe HC, Hansen BG et al. Linking metabolic QTLs with network and cis-eQTLs controlling biosynthetic pathways. PLoS Genet 2007; 3: 1687-1701. (Pubitemid 47510261)
61. Fu J, Keurentjes JJB, Bouwmeester H et al. System-wide molecular evidence for phenotypic buffering in Arabidopsis. Nat Genet 2009; 41: 166-167.
62. Jumbo-Lucioni P, Ayroles J, Chambers M et al. Systems genetics analysis of body weight and energy metabolism traits in Drosophila melanogaster. BMC Genomics 2010; 11: 297.
63. Nuzhdin SV, Brisson JA, Pickering A et al. Natural genetic variation in transcriptome reflects network structure inferred with major effect mutations: insulin/TOR and associated phenotypes in Drosophila melanogaster. BMC Genomics 2009; 10: 124.
64. Kopp JB, Winkler CA, Nelson GW. MYH9 genetic variants associated with glomerular disease: what is the role for genetic testing? Semin Nephrol 2010; 30: 409-417.